IBIO vs ARTV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

IBIO

45.1
AI Score
VS
ARTV Wins

ARTV

55.4
AI Score

Investment Advisor Scores

IBIO

45score
Recommendation
HOLD

ARTV

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO ARTV Winner
Revenue 100,000 31.14M ARTV
Net Income -8.99M -16.72M IBIO
Net Margin -8993.0% -53.7% ARTV
Operating Income -15.40M -18.70M IBIO
ROE -15.9% 11.0% ARTV
Cash 28.67M 65.89M ARTV
Free Cash Flow -11.45M -39.38M IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -14.1% · 3M: -30.6% ARTV 1M: -39.6% · 3M: -27.6%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 35

RSI (14): 34.8 · Price: $1.13

ARTV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 23

RSI (14): 22.6 · Price: $6.83

Fundamentals Snapshot

Metric IBIO ARTV
Market Cap — —
Forward P/E -3.6 -2.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% -1.0%
Gross Margin 1.0% —
Operating Margin -301.4% 0.0%
EPS -0.30 -3.23
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ARTV is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.